Expert Commentary

How to assess a patient for a bisphosphonate drug holiday

OBG Manag. 2017 December;29(12)
By
Michael R. McClung, MD
Author and Disclosure Information

Dr. McClung also discusses long-term denosumab therapy

 

Recorded at the 2017 meeting of the North American Menopause Society

Recommended Reading

VIDEO: Dr. Andrew Kaunitz’s top lessons from NAMS 2017
MDedge ObGyn
VIDEO: Expert roundtable on hormone therapy
MDedge ObGyn
Clinical pearls from NAMS 2017
MDedge ObGyn
Strategies to evaluate postmenopausal bleeding
MDedge ObGyn
Papillary thyroid microcarcinoma: Is ‘less is more’ the right approach?
MDedge ObGyn
Did long-term follow-up of WHI participants reveal any mortality increase among women who received HT?
MDedge ObGyn
Morphology index guides adnexal mass workup in postmenopausal women
MDedge ObGyn
Beyond the Kegel: the who, why, and how of pelvic floor PT
MDedge ObGyn
Hypoactive sexual desire disorder: The ideal patient for treatment with flibanserin
MDedge ObGyn
2017 Update on bone health
MDedge ObGyn

Related Articles